Ultraviolet radiation exposure and risk of malignant lymphomas

Journal of the National Cancer Institute

Volumn 97, Issue 3, 2005, Pages 199-209

  Smedby, Karin Ekström ^a   Hjalgrim, Henrik ^b   Melbye, Mads ^b   Torrång, Anna ^a   Rostgaard, Klaus ^b   Munksgaard, Lars ^b,c   Adami, Johanna ^a,d   Hansen, Mads ^e   Porwit MacDonald, Anna ^a   Jensen, Bjarne Anker ^f   Roos, Göran ^g   Pedersen, Bjarne Bach ^h   Sundström, Christer ⁱ   Glimelius, Bengt ^d,i   Adami, Hans Olov ^a,j  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Rigshospitalet   (Denmark)

^f HILLERØD HOSPITAL   (Denmark)

^g UMEÅ UNIVERSITY   (Sweden)

^h VIBORG HOSPITAL   (Denmark)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j HARVARD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; EYE COLOR; FEMALE; HAIR COLOR; HODGKIN DISEASE; HUMAN; HYPOTHESIS; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PATIENT INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SKIN CANCER; STATISTICAL ANALYSIS; SUN EXPOSURE; SUNBURN; SWEDEN; T CELL LYMPHOMA; TRAVEL; ULTRAVIOLET RADIATION; CONFIDENCE INTERVAL; EPIDEMIOLOGY; INCIDENCE; LYMPHOMA; MIDDLE AGED; QUESTIONNAIRE; RISK; STATISTICAL MODEL;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DENMARK; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LOGISTIC MODELS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; ULTRAVIOLET RAYS;

EID: 13744258994     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji022     Document Type: Article

References (45)

1. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer 1992;70:840-9.
2. Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994;14:387-94.
3. Melbye M, Adami HO, Hjalgrim H, Glimelius B. Ultraviolet light and non-Hodgkin's lymphoma. Acta Oncol 1996;35:655-7.
4. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995;310:1491-5.
5. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996;125:815-21.
6. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847-50.
7. Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11:891-7.
8. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001;91: 874-80.
9. McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 2000;143:171-3.
10. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995;141:916-22.
11. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995;61:773-9.
12. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997;146:734-9.
13. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147:722-6.
14. Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 2001;85:997-1005.
15. Hemminki K, Jiang Y, Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies markers of impaired immune function? Eur J Cancer 2003;39:223-9.
16. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996;73:945-50.
17. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996;312:1128-31.
18. Langford IH, Bentham G, McDonald AL. Mortality from non-Hodgkin lymphoma and UV exposure in the European community. Health Place 1998;4:355-64.
19. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 1996;88:298-300.
20. Newton R. Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin's lymphoma. BMJ 1997;314:1483-4.
21. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003;164:371-7.
22. Hu S, Ma F, Collado-Mesa F, Kirsner RS. Ultraviolet radiation and incidence of non-Hodgkin's lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev 2004;13:59-64.
23. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75.
24. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12:552-7.
25. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997;314:1451-5.
26. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641-5.
27. van Wijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 2001;43:548-53.
28. Norval M. Effects of solar radiation on the human immune system. J Photochem Photobiol B 2001;63:28-40.
29. Garssen J, van der Molen R, de Klerk A, Norval M, van Loveren H. Effects of UV irradiation on skin and nonskin-associated herpes simplex virus infections in rats. Photochem Photobiol 2000;72:645-51.
30. Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet 2003;362: 139-46.
31. Zheng T, Owens PH. Sunlight and non-Hodgkin's lymphoma. Int J Cancer 2000;87:884-6.
32. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2001.
33. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
34. d'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991;27:1201-8.
35. Brandberg Y, Sjoden PO, Rosdahl I. Assessment of sun-related behaviour in individuals with dysplastic naevus syndrome: a comparison between diary recordings and questionnaire responses. Melanoma Res 1997;7:347-51.
36. Melbye M, Trichopoulos, D. Non-Hodgkin's lymphomas. In: Adami HO, Hunter, D, Trichopoulos, D, editors. Textbook of cancer epidemiology. 1st ed. New York (NY): Oxford University Press; 2002. p. 535-49.
37. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-871.
38. Newton R, Roman E, Fear N, Carpenter L. Non-Hodgkin's lymphoma and solar ultraviolet radiation. Data are inconsistent. BMJ 1996;313:298.
39. Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003;4:161-8.
40. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol 2000;12:383-94.
41. Holick MF. Vitamin D: a millenium perspective. J Cell Biochem 2003; 88:296-307.
42. 3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993;68:668-72.
43. Askling J, Sorensen P, Ekbom A, Frisch M, Melbye M, Glimelius B, et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann Intern Med 1999;131:655-9.
44. Hjalgrim H, Frisch M, Storm HH, Glimelius B, Pedersen JB, Melbye M. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Int J Cancer 2000;85:639-42.
45. Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998;280:910-2.